Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,412 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial.
Kaku K, Inoue S, Matsuoka O, Kiyosue A, Azuma H, Hayashi N, Tokudome T, Langkilde AM, Parikh S. Kaku K, et al. Among authors: hayashi n. Diabetes Obes Metab. 2013 May;15(5):432-40. doi: 10.1111/dom.12047. Epub 2013 Jan 25. Diabetes Obes Metab. 2013. PMID: 23194084 Clinical Trial.
Linagliptin monotherapy provides superior glycaemic control versus placebo or voglibose with comparable safety in Japanese patients with type 2 diabetes: a randomized, placebo and active comparator-controlled, double-blind study.
Kawamori R, Inagaki N, Araki E, Watada H, Hayashi N, Horie Y, Sarashina A, Gong Y, von Eynatten M, Woerle HJ, Dugi KA. Kawamori R, et al. Among authors: hayashi n. Diabetes Obes Metab. 2012 Apr;14(4):348-57. doi: 10.1111/j.1463-1326.2011.01545.x. Epub 2012 Jan 17. Diabetes Obes Metab. 2012. PMID: 22145698 Clinical Trial.
Phase II study of S-1 monotherapy in patients with previously treated, advanced non-small-cell lung cancer.
Wada M, Yamamoto M, Ryuge S, Nagashima Y, Hayashi N, Maki S, Otani S, Katono K, Takakura A, Yanaihara T, Igawa S, Yokoba M, Mitsufuji H, Kubota M, Katagiri M, Masuda N. Wada M, et al. Among authors: hayashi n. Cancer Chemother Pharmacol. 2012 Apr;69(4):1005-11. doi: 10.1007/s00280-011-1795-5. Epub 2011 Dec 8. Cancer Chemother Pharmacol. 2012. PMID: 22160350 Clinical Trial.
Successful treatment of myeloma cast nephropathy using bortezomib-based chemotherapy plus selective plasma exchange.
Kawabe M, Yamamoto I, Katsuma A, Hayashi N, Komatsuzaki Y, Nakada Y, Shimizu A, Tanno Y, Ohkido I, Tsuboi N, Suzuki K, Shimada T, Ogasawara Y, Sugiyama K, Aiba K, Yokoo T. Kawabe M, et al. Among authors: hayashi n. CEN Case Rep. 2016 Nov;5(2):232-237. doi: 10.1007/s13730-016-0231-4. Epub 2016 Aug 11. CEN Case Rep. 2016. PMID: 28508984 Free PMC article.
Pegylated interferon alpha-2b (Peg-IFN alpha-2b) affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with Peg-IFN alpha-2b plus ribavirin.
Oze T, Hiramatsu N, Yakushijin T, Kurokawa M, Igura T, Mochizuki K, Imanaka K, Yamada A, Oshita M, Hagiwara H, Mita E, Ito T, Inui Y, Hijioka T, Tamura S, Yoshihara H, Hayashi E, Inoue A, Imai Y, Kato M, Yoshida Y, Tatsumi T, Ohkawa K, Kiso S, Kanto T, Kasahara A, Takehara T, Hayashi N. Oze T, et al. Among authors: hayashi e, hayashi n. J Viral Hepat. 2009 Aug;16(8):578-85. doi: 10.1111/j.1365-2893.2009.01116.x. Epub 2009 Jun 22. J Viral Hepat. 2009. PMID: 19552663
Changes in tumor expression of HER2 and hormone receptors status after neoadjuvant chemotherapy in 21,755 patients from the Japanese breast cancer registry.
Niikura N, Tomotaki A, Miyata H, Iwamoto T, Kawai M, Anan K, Hayashi N, Aogi K, Ishida T, Masuoka H, Iijima K, Masuda S, Tsugawa K, Kinoshita T, Nakamura S, Tokuda Y. Niikura N, et al. Among authors: hayashi n. Ann Oncol. 2016 Mar;27(3):480-7. doi: 10.1093/annonc/mdv611. Epub 2015 Dec 23. Ann Oncol. 2016. PMID: 26704052 Free article.
3,412 results